Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
Shinobu ShimizuMasahiro IijimaYuki FukamiNatsuko TamuraMasahiro NakatochiMasahiko AndoRyoji NishiHaruki KoikeKen-Ichi KaidaMichiaki KogaTakashi KandaHidenori OgataJun-Ichi KiraMasahiro MoriSatoshi KuwabaraMasahisa KatsunoPublished in: JMIR research protocols (2020)
DERR1-10.2196/17117.